Current trends in the teatment of multiple sclerosis
Authors:
Jana Libertínová
Authors‘ workplace:
Neurologická klinika, 2. LF UK Praha
Published in:
Čes. slov. Farm., 2025; 74, 158-163
doi:
https://doi.org/10.36290/csf.2025.028
Overview
Multiple sclerosis is a chronic disease of the central nervous system, in the pathogenesis of which both autoimmune inflammation and neurodegeneration play a role. It is a serious disease diagnosed most often in young adulthood and, without treatment, is the most common cause of non-traumatic disability at this age. Therapy, which is currently available immediately after diagnosis, leads to a significant improvement in the prognosis and quality of life of patients.
Keywords:
Multiple sclerosis – Pathogenesis – disease-modifying drugs – highly effective treatment
Labels
Pharmacy Clinical pharmacologyArticle was published in
Czech and Slovak Pharmacy
2025 Issue 3
Most read in this issue
- Medications with dependence potential: Pharmacological aspects and clinical practise
- ADME Profile Calculation and Drug Similarity Study of New 1,2,4-Triazole Derivatives Containing 2-Bromo-5-Methoxyphenyl Radical
- Individually prepared medicinal products in palliative care
- Periodontitis: pharmacist's options in its prevention and treatment